$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC. Stock $boty

$boty Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000164033422001180 Filed on June 03, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$32.27K	$21.17K	$19.10K
YoY Change	17.66%	199.11%	231.6%
Cost Of Revenue	$14.96K	$0.00	$29.59K
YoY Change	197.42%	-100.0%	1543.89%
Gross Profit	$17.32K	$21.17K	-$10.49K
YoY Change	-22.7%	-251.95%	-364.9%
Gross Profit Margin	53.65%	100.0%	-54.92%
Selling, General & Admin	$53.60K	$80.81K	$195.2K
YoY Change	-26.47%	35.11%	206.34%
% of Gross Profit	309.54%	381.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$49.70K	$80.81K	$195.2K
YoY Change	-31.82%	35.12%	206.33%
Operating Profit	-$32.38K	-$59.65K	-$205.7K
YoY Change	-35.86%	-19.11%	244.18%
Interest Expense	$68.62K	$112.5K	$8.184M
YoY Change	-90.27%	-4.51%	-337.86%
% of Operating Profit
Other Income/Expense, Net	$972.7K	$863.6K	-$3.000K
YoY Change	37.96%	-111.56%	-113.72%
Pretax Income	$940.3K	$804.0K	$7.975M
YoY Change	43.66%	-110.65%	-329.27%
Income Tax
% Of Pretax Income
Net Earnings	$940.3K	$804.0K	$7.975M
YoY Change	43.66%	-110.65%	-329.27%
Net Earnings / Revenue	2913.65%	3798.65%	41754.66%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$227.40	$2.364K
COMMON SHARES
Basic Shares Outstanding	3.535B shares		3.291B shares
Diluted Shares Outstanding	10.10B shares	9.669B shares

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.67K	$14.80K	$34.48K
YoY Change	-80.19%	-90.93%	732.85%
Cash & Equivalents	$25.67K	$14.80K	$34.48K
Short-Term Investments
Other Short-Term Assets	$7.500K	$7.500K	$7.500K
YoY Change
Inventory
Prepaid Expenses	$7.500K	$7.500K	$7.500K
Receivables
Other Receivables
Total Short-Term Assets	$33.17K	$22.30K	$41.98K
YoY Change	-74.4%	-86.34%	913.54%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$3.00	-$1.00
YoY Change			-50.0%
TOTAL ASSETS
Total Short-Term Assets	$33.17K	$22.30K	$41.98K
Total Long-Term Assets	$0.00	$3.00	-$1.00
Total Assets	$33.17K	$22.30K	$41.98K
YoY Change	-74.4%	-86.34%	914.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$500.2K	$482.7K	$465.2K
YoY Change	17.36%	17.39%	19.68%
Accrued Expenses	$334.8K	$282.5K	$231.8K
YoY Change	54.39%	8.93%	-19.34%
Deferred Revenue
YoY Change
Short-Term Debt	$878.0K	$861.6K	$799.8K
YoY Change	29.78%	54.44%	50.44%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.088M	$6.017M	$6.841M
YoY Change	-57.09%	-54.15%	16.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.088M	$6.017M	$6.841M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$5.088M	$6.017M	$6.841M
YoY Change	-57.09%	-54.15%	16.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.977M	-$10.92M	-$11.72M
YoY Change			42.98%
Common Stock	$3.535M	$3.535M	$3.535M
YoY Change			51.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.055M	-$5.995M	-$6.799M
YoY Change
Total Liabilities & Shareholders Equity	$33.17K	$22.30K	$41.98K
YoY Change	-74.4%	-86.34%	913.54%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	$940.3K	$804.0K	$7.975M
YoY Change	43.66%	-110.65%	-329.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$34.13K	-$19.68K	-$95.15K
YoY Change	82.61%	-80.0%	171.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	45.00K	$0.00	63.50K
YoY Change	-400.0%	-100.0%	65.58%
NET CHANGE
Cash From Operating Activities	-34.13K	-$19.68K	-95.15K
Cash From Investing Activities	0.000	$0.00
Cash From Financing Activities	45.00K	$0.00	63.50K
Net Change In Cash	10.87K	-$19.68K	-31.65K
YoY Change	-132.26%	-112.37%	-1044.78%
FREE CASH FLOW
Cash From Operating Activities	-$34.13K	-$19.68K	-$95.15K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3535302536	shares
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	14797	USD
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	34481	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7500	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7500	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	22297	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	41981	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	43314	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	20849	USD
CY2022Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	482668	USD
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	465168	USD
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	282544	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	231839	USD
CY2022Q1	boty	Promissory Note Debt Discount PromissoryNoteDebtDiscount	27397	USD
CY2021Q4	boty	Promissory Note Debt Discount PromissoryNoteDebtDiscount	89183	USD
CY2022Q1	boty	Promissory Notes Payable Current PromissoryNotesPayableCurrent	312603	USD
CY2021Q4	boty	Promissory Notes Payable Current PromissoryNotesPayableCurrent	250817	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	USD
CY2022Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	549010	USD
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	549010	USD
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	4346984	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5323107	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6017122	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6840790	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	51	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3535302536	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	3535303	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3535303	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1387030	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1387030	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10917157	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11721142	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6798809	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22297	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41981	USD
CY2022Q1	us-gaap	Revenues Revenues	21165	USD
CY2021Q1	us-gaap	Revenues Revenues	7076	USD
CY2022Q1	boty	Cost Of Service CostOfService	0	USD
CY2021Q1	boty	Cost Of Service CostOfService	21005	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	21165	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	-13929	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14912	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24557	USD
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	35900	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	5250	USD
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	30000	USD
CY2021Q1	us-gaap	Salaries And Wages SalariesAndWages	30000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	80812	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	59807	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-59648	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-73736	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	112491	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	117810	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	976124	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-7355494	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	863633	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7473304	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	803985	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7547040	USD
CY2022Q1	boty	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	0.00
CY2021Q1	boty	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.00
CY2022Q1	boty	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	3535302536	shares
CY2022Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-976124	USD
CY2021Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	7355494	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	61786	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19684	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	159096	USD
CY2021Q1	boty	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	2612776754	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6798809	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	803985	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-5994824	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-5878867	USD
CY2021Q1	boty	Shares Of Common Stock Issued For Conversion Of Debts And Accrued Interest Amount SharesOfCommonStockIssuedForConversionOfDebtsAndAccruedInterestAmount	9571	USD
CY2021Q1	boty	Shares Of Common Stock Issued For Exercise Of Warrants Amount SharesOfCommonStockIssuedForExerciseOfWarrantsAmount	0	USD
CY2021Q1	boty	Write Off Of Convertible Notes And Accrued Interest WriteOffOfConvertibleNotesAndAccruedInterest	110076	USD
CY2021Q1	boty	Derivative Liabilities Reclass To Additional Paid In Capital Due To Note Conversion Warrant Exercise And Note Written Off DerivativeLiabilitiesReclassToAdditionalPaidInCapitalDueToNoteConversionWarrantExerciseAndNoteWrittenOff	346640	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7547040	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-12959620	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-7547040	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	85376	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	17500	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	30000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	22464	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-54669	USD
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	50705	USD
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	32435	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19684	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-98404	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2022Q1	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	0	USD
CY2021Q1	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	7500	USD
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2021Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	265000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	257500	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34481	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4142	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14797	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163238	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	0	USD
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	265000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	346640	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	9571	USD
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	65484	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	110076	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34481	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lingerie Fighting Championships, Inc. (the “Company”) is a Nevada corporation incorporated on November 29, 2006 under the name Sparking Events, Inc. The Company’s corporate name was changed to Xodtec Group USA, Inc. in June 2009, Xodtec LED, Inc. in May 2010, Cala Energy Corp. in September 2013 and Lingerie Fighting Championships, Inc. on April 1, 2015.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company focuses on developing, producing, promoting, and distributing entertainment through live entertainment events, digital home videos, broadcast television networks, video on demand, and digital media channels in the United States. It offers wrestling and mixed martial arts fights featuring women under the LFC brand name.</p>
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company continually evaluates its estimates and judgments. The Company bases its estimates and judgments on historical experience and other factors that it believes to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.</p>
CY2022Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior period amounts have been reclassified to conform with the current year presentation.</p>
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14797	USD
CY2022Q1	us-gaap	Revenues Revenues	21165	USD
CY2021Q1	us-gaap	Revenues Revenues	7076	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	21005	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	21165	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	-13929	USD
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6133290889	shares
CY2020Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5711244622	shares
CY2022Q1	boty	Related Party Balances And Transactionspolicytextblock RelatedPartyBalancesAndTransactionspolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows FASB ASC 850, “<em>Related Party Disclosures</em>,” for the identification of related parties and disclosure of related party transaction. (See Note 9)</p>
CY2022Q1	us-gaap	Derivative Assets DerivativeAssets	0	USD
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	4346984	USD
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	0	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	5323107	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2657000	USD
CY2022Q1	boty	Closing Market Price ClosingMarketPrice	0.0006
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5556666666	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5556666666	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	51	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	51	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	51	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3535302536	shares
CY2020Q4	boty	Outstanding Warrants Balances Beginning OutstandingWarrantsBalancesBeginning	5438166666	shares
CY2020Q4	boty	Outstanding Warrants Exercise Price OutstandingWarrantsExercisePrice	0.0001
CY2021	boty	Granted Granted	400000000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0002
CY2021	boty	Exercised Exercised	-281500000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0003
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5556666666	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0001
CY2021Q4	boty	Outstanding Warrants Balances Beginning OutstandingWarrantsBalancesBeginning	5556666666	shares
CY2021Q4	boty	Outstanding Warrants Exercise Price OutstandingWarrantsExercisePrice	0.0001
CY2021Q1	us-gaap	Option Indexed To Issuers Equity Strike Price1 OptionIndexedToIssuersEquityStrikePrice1	0.0002
CY2022Q1	boty	Expected Term ExpectedTerm	P3Y6M18D
CY2021Q1	boty	Expected Term ExpectedTerm	P5Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.37	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0077	pure
CY2021Q1	boty	Warrants Derivative Amount WarrantsDerivativeAmount	265000	USD
CY2021Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	248077	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3324010	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4444017	shares
CY2022Q1	boty	Note6 Promissory Note Note6PromissoryNote	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 6 – PROMISSORY NOTES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company had the following promissory notes payable as at March 31, 2022 and December 31, 2021:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Promissory Notes to Auctus Fund</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less Debt Discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(27,397</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(89,183</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Promissory Notes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">312,603</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">250,817</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 4, 2021, the Company entered into an agreement with Auctus Fund, LLC to issue a senior secured promissory note of $300,000 to the unrelated party, which bears interest at 12% of the principal amount. The promissory note matures on March 4, 2022. In conjunction with the convertible note, the Company issued warrants to purchase 150,000,000 shares of common stock, exercisable for five years from issuance at $0.002 per share and returnable warrants to purchase 150,000,000 shares of common stock, exercisable for five years form issuance at $0.002 per share which will be automatically expired in the event that the Company repays the convertible promissory notes prior to its maturity date. (See Note 5) The note was discounted for original issued discount of $35,000 and a derivative on warrants of $265,000 for an aggregate discount of $300,000, which is being amortized over the life of the note using the effective interest method resulting in $248,077 of debt discount amortization for the year ended December 31, 2021. As of March 31, 2022, the note is presented at $300,000, net of debt discount of $0.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 6, 2021, the Company entered into an agreement with Auctus Fund, LLC to issue a senior secured promissory note of $40,000 to the unrelated party, which bears interest at 12% of the principal amount. The promissory note matures on December 6, 2022. In conjunction with the convertible note, the Company issued first common stock purchased warrants to purchase 50,000,000 shares of common stock, exercisable for five years from issuance at $0.0008 per share and second common stock purchased warrants to purchase 50,000,000 shares of common stock, exercisable for five years form issuance at $0.0008 per share which will be automatically expired in the event that the Company repays the convertible promissory notes prior to its maturity date. (See Note 5) The note was discounted for original issued discount of $9,000 and a derivative on warrants of $31,000 for an aggregate discount of $40,000, which is being amortized over the life of the note using the effective interest method resulting in $2,740 of debt discount amortization for the year ended December 31, 2021. As of March 31, 2022, the note is presented at $12,603, net of debt discount of $27,397.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2022 and 2021, interest expense of $13,019 and $2,663 was incurred on the promissory notes. As of March 31, 2022 and December 31, 2021, accrued interest payable on the promissory note was $46,027 and $33,008, respectively.</p>
CY2022Q1	boty	Schedule Of Promissory Notes Payable ScheduleOfPromissoryNotesPayable	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Promissory Notes to Auctus Fund</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">340,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less Debt Discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(27,397</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(89,183</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total Promissory Notes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">312,603</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">250,817</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021Q4	boty	Promissory Notes To Auctus Fund PromissoryNotesToAuctusFund	340000	USD
CY2022Q1	boty	Promissory Notes To Auctus Fund PromissoryNotesToAuctusFund	340000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	27397	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	89183	USD
CY2022Q1	us-gaap	Notes Payable NotesPayable	312603	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	250817	USD
CY2021Q1	boty	Debt Instrument Aggregate Discount DebtInstrumentAggregateDiscount	300000	USD
CY2021Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	35000	USD
CY2021Q4	boty	Debt Instrument Aggregate Discount DebtInstrumentAggregateDiscount	40000	USD
CY2021Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	9000	USD
CY2021Q4	boty	Warrants Derivative Amount WarrantsDerivativeAmount	31000	USD
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2740	USD
CY2022Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	549010	USD
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	549010	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	5323107	USD
CY2022Q1	boty	Gain On Change In Fair Value Of The Derivative GainOnChangeInFairValueOfTheDerivative	-976124	USD
CY2021Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-7355494	USD
CY2022Q1	boty	Loss Due To Derivative Liabilities On Warrants LossDueToDerivativeLiabilitiesOnWarrants	0	USD
CY2021Q1	boty	Loss Due To Derivative Liabilities On Warrants LossDueToDerivativeLiabilitiesOnWarrants	-346970	USD
CY2022Q1	boty	Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants	-976124	USD
CY2021Q1	boty	Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants	-7008524	USD
CY2022Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-976124	USD
CY2022Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	482668	USD
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	465168	USD

Files In Submission

Name	View Source	Status
0001640334-22-001180-index-headers.html	Edgar Link	pending
0001640334-22-001180-index.html	Edgar Link	pending
0001640334-22-001180.txt	Edgar Link	pending
0001640334-22-001180-xbrl.zip	Edgar Link	pending
boty-20220331.xsd	Edgar Link	pending
boty-20220331_cal.xml	Edgar Link	unprocessable
boty-20220331_def.xml	Edgar Link	unprocessable
boty-20220331_lab.xml	Edgar Link	unprocessable
boty-20220331_pre.xml	Edgar Link	unprocessable
boty_10q.htm	Edgar Link	pending
boty_10q_htm.xml	Edgar Link	completed
boty_ex311.htm	Edgar Link	pending
boty_ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC. Stock $boty

2022 Q2 Form 10-Q Financial Statement

#000164033422001180 Filed on June 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOTY LINGERIE FIGHTING CHAMPIONSHIPS, INC. Stock $boty

2022 Q2 Form 10-Q Financial Statement

#000164033422001180 Filed on June 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC. Stock $boty